UNIVERCELLS

Every cancer diagnosis brings urgency. Urgency for answers, for treatments, and for hope. But for too many people, the barriers are overwhelming: 🔹Time: treatments take years to develop, while patients can’t wait. 🔹Cost: even when treatments are available, the price can be out of reach, turning hope into heartbreak. 🔹Access: where you live still determines whether you receive the care you need - or any care at all. These challenges aren’t just statistics - they’re deeply human. Behind every delay, every barrier, there’s a person: someone’s parent, partner, child, or friend. At UNIVERCELLS, we see RNA-based innovations as vital to overcoming the hurdles patients face. From design to delivery, our solutions help accelerate the development of cancer therapies, reduce their costs, and improve access for people, everywhere. Because when it comes to cancer, saving time can change lives. Find out more: https://lnkd.in/eNy4b7sc #BiotechInnovation #RNASolutions #AccessToTreatment

What is RNA, and why is it important? RNA (ribonucleic acid) plays a central role in life. It’s the molecule that translates genetic instructions into action, telling our cells how to make the proteins they need to function. A decade ago, we couldn’t imagine the extraordinary possibilities that RNA has unlocked in medicine: ✅ mRNA vaccines for faster responses to global health crises. ✅ Personalized cancer therapies tailored to individual patients. ✅ Innovative treatments for rare and complex diseases. At UNIVERCELLS, we accelerate the development of RNA-based vaccines and therapies. From design to delivery, our solutions help make life-saving treatments more accessible to people, everywhere. Curious to see how we’re making a difference? https://lnkd.in/eZJVATwt #BiotechInnovation #RNASolutions #AccessToTreatment 

Exciting News! We’re partnering with the University of Oxford - Oxford Cancer, the Oxford Vaccine Group, and the Pandemic Sciences Institute - to advance RNA vaccine development and accessibility for infectious diseases and cancer. RNA vaccines have incredible potential to reshape healthcare, using genetic instructions to create immune responses that can prevent or treat disease. With Oxford's expertise in vaccine research and UNIVERCELLS' innovative RNA technology, we’re working to accelerate access to transformative and effective treatments. Our goal? More affordable, personalized cancer therapies and essential vaccines for diseases like dengue, Zika, and yellow fever. This partnership is about turning innovation into real-world impact. Together, we're pushing the boundaries of what’s possible in health. Find out more: https://lnkd.in/eUGvysHN #BiotechInnovation #CancerResearch #InfectiousDiseases Oxford University Department of Paediatrics, Nuffield Department of Medicine

The recent transmission of H5N1 bird flu to a pig in the Unites States is a wake-up call.    It highlights the virus’ ability to spread across species, and the importance of vaccinating against #AvianInfluenza. If bird flu continues to spread among animals, the impact on food production and security could be severe. There’s also a risk that pigs, which can act as “mixing vessels” for viruses, may facilitate gene exchange between avian and human viruses, potentially heightening the risk of human infection.   Vaccination, alongside vigilant surveillance, is essential. By protecting poultry and other animals, we can reduce the risk of cross-species transmission, safeguarding both animal and human health. These proactive measures also help secure global food supply chains, supporting food security worldwide.   At UNIVERCELLS, we're advancing biotech for human and animal health. Our RNA Design-to-Delivery Solutions for livestock prophylactic vaccines enable scalable, high-yield production and integrate novel delivery systems to foster protective immunity across various diseases and species, allowing rapid responses to outbreaks and new variants.   For more background information, you can find a link to the news article in the comments.   #BiotechInnovation #OneHealth 

We’re feeling incredibly inspired here at #BioEurope2024! It’s energizing to connect with biotech and pharma leaders, exchange insights on the future of healthcare, and explore how we can break down barriers to make innovative treatments more accessible to people everywhere. From discussions on oncology, vaccines, and solutions for both human and animal health, to forging potential new collaborations - it’s truly an impactful experience all around! If you’re attending and we haven’t met yet, come say hello. We’d love to connect and discuss how we can work together to transform healthcare globally. #BiotechInnovation #PartnershipsForHealth 

Hala Audi, our Chief Alliance Officer, joined the Platform Technologies Workshop as a panelist at the World Vaccine Congress Europe on Monday, October 28. Thank you to everyone who attended and engaged in the discussion on the expansion of RNA “everything and everywhere.” We’re grateful for the chance to connect and exchange insights on the future of vaccine technology with such a thoughtful audience. We look forward to continuing these essential conversations together. #WVCEU #vaccinetechnology #innovation UNIVERCELLS

We’re excited to attend #BioEurope2024 next week, the premier biotech and pharma collaboration event. At UNIVERCELLS our purpose is clear: to transform how biotech drugs are made so everyone, everywhere, can get them. We’re eager to connect with stakeholders who share our vision of making healthcare more accessible – so don’t hesitate to connect with us in Stockholm and see how we can collaborate to make a global impact! #BiotechInnovation #PartnershipsForHealth Laurie Clotilde,

UNIVERCELLS is excited to participate in The World Vaccine Congress Europe 2024 next week! We’ll be meeting with global experts and innovators to discuss the latest in vaccine development and manufacturing. From improving vaccine accessibility to exploring cutting-edge technologies like mRNA and beyond, we aim to transform how biotech drugs are made, helping to make life-saving treatments more accessible and affordable to people, wherever they are. We look forward to connecting with leaders and partners as we continue pushing the boundaries of biotech innovation! #WorldVaccineCongress #BiotechInnovation #AccessToInnovation Maria Davila-Saignol

As bird flu continues its global spread, impacting both wild birds and poultry, it’s time to rethink how we manage this threat. The virus is deeply rooted in wildlife, and the poultry industry faces constant risk. A promising solution? Avian influenza vaccination. Wider vaccination can help sustain poultry production, improve animal welfare, and limit economic damage. It’s also a crucial step to protect wildlife and prevent human infections. At UNIVERCELLS, we’re driving advancements in biotechnologies, such as RNA vaccines, which can help transform our approach to avian influenza. Next week, our team will join global experts at the #HPAI2024 Conference to address this critical issue. We hope to see you there! Together, we can protect animals and humans by harnessing the latest in biotech to stay ahead of the curve. #AvianInfluenza #BiotechInnovation

Cancer touches us all. Whether it’s someone we love or a personal battle, its impact is an everyday reality. With nearly 20 million new cases diagnosed globally each year, faster, more affordable access to treatment is critical. New cancer therapies offer hope thanks to scientific breakthroughs, but high costs and long development times leave many patients waiting. At UNIVERCELLS we believe no one should have to wait for life-saving treatments. We’re developing technologies to accelerate production, make them more affordable, and get therapies to patients more quickly through localized manufacturing. Cancer shouldn’t win because of time or cost. We're transforming how biotech drugs are made to ensure life-saving treatments reach those who need them most. Find out more about what we do here: https://lnkd.in/eNy4b7sc #BiotechInnovation #Oncology #AcessToTherapies